---
title: "Transchem Ltd (TRANSCHEM) — Share Price, Financials & Analysis"
symbol: "TRANSCHEM"
company: "Transchem Ltd"
canonical: "https://tapetide.com/stocks/TRANSCHEM"
bse_code: "500422"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
generated_at: "2026-09-13T18:59:14.389Z"
---

# Transchem Ltd (TRANSCHEM)

Canonical page: https://tapetide.com/stocks/TRANSCHEM

## Company

- **BSE Code:** 500422
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** transchem.net

## About

Transchem Ltd has transitioned from 
mushroom manufacturing and exports 
to financial services. After selling its non-operational Pune mushroom undertaking 
in 2020, it primarily earned through inter-corporate deposits and treasury investments.[1][2]

## Latest Price

## Key Insights

### Strengths

- Company is almost debt free.

### Weaknesses

- Stock is trading at 5.58 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 5.98% over last 3 years.
- Earnings include an other income of Rs.12.7 Cr.

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| net income growth | 48% | 58% | 14% |
| revenue growth | -100% | — | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0 | 0 | 0.41 | 0 | 0 | 0.21 | 2.42 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.39 | 0.5 | 0.86 | 0.27 | 0.37 | 0.54 | 2.9 | 0.29 | 0.75 | 1.31 | 1.31 | 0.7 |
| Operating Profit | -0.39 | -0.5 | -0.45 | -0.27 | -0.37 | -0.33 | -0.48 | -0.29 | -0.75 | -1.31 | -1.31 | -0.7 |
| OPM % | — | — | -109.76 | — | — | -157.14 | -19.83 | — | — | — | — | — |
| Other Income | 1.69 | 2.02 | 2.16 | 2.47 | 2.31 | 2.19 | 1.56 | 1.64 | 1.68 | 2.25 | 3.7 | 5.11 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 |
| Profit before tax | 1.3 | 1.52 | 1.71 | 2.2 | 1.94 | 1.86 | 1.08 | 1.35 | 0.93 | 0.94 | 2.39 | 4.35 |
| Tax % | 25.38 | 25.66 | 26.9 | 24.09 | 25.26 | 25.27 | 32.41 | 26.67 | 27.96 | 43.62 | 12.55 | 21.38 |
| Net Profit | 0.97 | 1.14 | 1.25 | 1.66 | 1.44 | 1.39 | 0.73 | 0.99 | 0.68 | 0.53 | 2.09 | 3.42 |
| EPS in Rs | 0.79 | 0.93 | 1.02 | 1.36 | 1.18 | 1.14 | 0.6 | 0.81 | 0.56 | 0.43 | 1.71 | 2.79 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0 | 0 | 0 | -0.05 | -0.2 | 0 | 0.34 | 2.63 | 0 | 0 |
| Expenses | 1.69 | 1.18 | 1.39 | 1.88 | 2.54 | 1.73 | 2.08 | 4.09 | 3.63 | 4.07 |
| Operating Profit | -1.69 | -1.18 | -1.39 | -1.93 | -2.74 | -1.73 | -1.74 | -1.46 | -3.63 | -4.07 |
| OPM % | — | — | — | — | — | — | -511.76 | -55.51 | — | — |
| Other Income | 2.11 | 2.75 | 2.76 | 26.82 | 6.66 | 4.24 | 7.4 | 8.53 | 9.25 | 12.74 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 |
| Depreciation | 0.97 | 0.8 | 0.57 | 0.12 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.05 |
| Profit before tax | -0.55 | 0.77 | 0.8 | 24.77 | 3.91 | 2.5 | 5.65 | 7.06 | 5.61 | 8.61 |
| Tax % | 116.36 | 61.04 | 47.5 | 2.5 | 26.6 | 50.8 | 25.66 | 26.06 | 23.53 | — |
| Net Profit | -1.19 | 0.31 | 0.41 | 24.15 | 2.87 | 1.24 | 4.2 | 5.23 | 4.3 | 6.72 |
| EPS in Rs | -0.97 | 0.25 | 0.33 | 19.73 | 2.34 | 1.01 | 3.43 | 4.27 | 3.51 | 5.49 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 | 12.24 |
| Reserves | 25.75 | 24.57 | 25.74 | 24.53 | 50.7 | 54.06 | 53.6 | 63.41 | 67.08 | 71.34 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0.17 | 0.17 | 0.39 | 0.3 | 0.48 | 0.51 | 0.39 | 0.66 | 0.4 | 4.15 |
| Total Liabilities | 38.16 | 36.98 | 38.37 | 37.07 | 63.42 | 66.81 | 66.23 | 76.31 | 79.72 | 87.73 |
| Fixed Assets | 6.4 | 5.43 | 4.27 | 3.7 | 0.11 | 0.1 | 0.09 | 0.09 | 0.05 | 0.02 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 29.79 | 10.21 | 5.93 | 3.69 | 8.69 | 8.82 | 8.23 | 8.91 | 2.04 | 1.97 |
| Other Assets | 1.97 | 21.34 | 28.17 | 29.68 | 54.62 | 57.89 | 57.91 | 67.31 | 77.63 | 85.74 |
| Total Assets | 38.16 | 36.98 | 38.37 | 37.07 | 63.42 | 66.81 | 66.23 | 76.31 | 79.72 | 87.73 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0.55 | -19.79 | 10.34 | -0.63 | -27.72 | 21.91 | 1.22 | -39.31 | 36 | -2.89 |
| Cash from Investing Activity | -1.51 | 19.78 | 5.73 | 0.67 | 23.06 | 0.6 | -0.94 | 5.12 | 6.02 | 1.65 |
| Cash from Financing Activity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | -0.95 | -0.01 | 16.07 | 0.04 | -4.66 | 22.51 | 0.28 | -34.18 | 42.02 | -1.24 |
| Free Cash Flow | 0.55 | -19.79 | 10.53 | -0.63 | -1.79 | 21.91 | 1.22 | -39.31 | 36.53 | -1.31 |
| CFO/OP | -56 | 1165 | -897 | 0 | 1401 | -853 | -132 | 2182 | -2618 | 47 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | — | — | — | — | 0 | 0 | — | 440.15 | 376.1 | — |
| Inventory Days | 32485 | — | — | — | -511 | -273.75 | — | 0 | 0 | — |
| Days Payable | 0 | — | — | — | — | — | — | — | — | — |
| Cash Conversion Cycle | — | — | — | — | -511 | -273.75 | — | 440.15 | 376.1 | — |
| Working Capital Days | — | — | — | — | 311418 | 42705 | — | 71421.91 | 4856.03 | — |
| ROCE % | -0.58 | -1.47 | 1.63 | 2.03 | 4.61 | 4.22 | 3.5 | 7.99 | 9.11 | 6.9 |

## Shareholding Pattern

### annual

| Category | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 5.15% | 34.92% | 34.92% | 34.92% | 39.86% | 44.76% | 49.69% | 51.68% | 56.45% | 56.45% | 56.45% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% |
| DIIs | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public | 94.82% | 65.05% | 65.05% | 65.05% | 60.11% | 55.2% | 50.27% | 48.3% | 43.51% | 43.52% | 43.52% |
| No. of Shareholders | 13766 | 13349 | 13101 | 13039 | 13109 | 13577 | 13482 | 13813 | 13843 | 13145 | 13048 |

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 51.68% | 51.68% | 51.68% | 51.68% | 51.68% | 51.68% | 56.45% | 56.45% | 56.45% | 56.45% | 56.45% | 56.45% |
| FIIs | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% |
| DIIs | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public | 48.29% | 48.29% | 48.3% | 48.29% | 48.29% | 48.29% | 43.51% | 43.52% | 43.51% | 43.52% | 43.52% | 43.52% |
| No. of Shareholders | 13603 | 13615 | 13813 | 13681 | 13647 | 13835 | 13843 | 13767 | 13680 | 13339 | 13145 | 13048 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 13 / 2 / 4

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 365.04 | Buy |
| EMA (10) | 364.94 | Buy |
| SMA (20) | 346.62 | Buy |
| EMA (20) | 352.17 | Buy |
| SMA (50) | 335.92 | Buy |
| EMA (50) | 330.31 | Buy |
| SMA (100) | 288.29 | Buy |
| EMA (100) | 293.9 | Buy |
| SMA (200) | 223.6 | Buy |
| EMA (200) | 235.96 | Buy |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 78.58 | Sell |
| MACD (12,26,9) | 14.6 | Buy |
| Stochastic (14,3,3) | 90.35 | Sell |
| ADX (14) | 30.33 | Buy |
| Williams %R (14) | -9.51 | Sell |
| ATR (14) | 14.24 | High Volatility |
| ROC (12) | 14.99 | Buy |
| Stoch RSI (14) | 100 | Sell |
| UO (7,14,28) | 55.83 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 5 Sep - 49th AGM held; Greshma acquisition completed, warrants allotted, and authorised capital raised to ₹75 crore. | [Shareholder Meeting / Postal Ballot-Outcome of AGM 5 Sep - 49th AGM held; Greshma acquisition completed, warrants allotted, and authorised capital raised to ₹75 crore.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=619b5a24-23e4-46a0-8c9c-b52e97c6b7cb.pdf) |
| 17 Aug - Transchem acquired 100% of Greshma Shares and Stocks for ₹25.91 crore on August 17, 2026. | [Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements 17 Aug - Transchem acquired 100% of Greshma Shares and Stocks for ₹25.91 crore on August 17, 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85607289-4211-424f-af5f-acf320c68396.pdf) |
| 17 Aug - Transchem acquired 100% of Greshma Shares & Stocks for Rs 25.91 crore on August 17, 2026. | [Announcement under Regulation 30 (LODR)-Updates on Acquisition 17 Aug - Transchem acquired 100% of Greshma Shares & Stocks for Rs 25.91 crore on August 17, 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=847174c1-0557-4e55-94f6-b11eda550d18.pdf) |
| 10 Aug - Monitoring agency report for Q1 FY27 shows no deviation; preferential warrant proceeds remain unutilized in bank, FD, and liquid fund. | [Announcement under Regulation 30 (LODR)-Monitoring Agency Report 10 Aug - Monitoring agency report for Q1 FY27 shows no deviation; preferential warrant proceeds remain unutilized in bank, FD, and liquid fund.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=932b4c3f-7304-44f9-9d2b-6c4393504ab5.pdf) |
| 10 Aug - Board approved amended insider trading code on August 10, 2026. | [Amendment To The Code Of Conduct For Prevention Of Insider Trading 10 Aug - Board approved amended insider trading code on August 10, 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b1435fd3-bb39-48ba-8c03-a69f0a4d5fc7.pdf) |
| — | [Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 7 Sep](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a4a7d01-c7f1-494c-b8ff-e9b349637db9.pdf) |
| — | [Announcement under Regulation 30 (LODR)-Newspaper Publication 12 Aug](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d9135be-33c0-4965-8498-7f804d6e6064.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/15dfb7c1-0ad3-41b3-b2be-1fbaee0bff4c.pdf) |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=15dfb7c1-0ad3-41b3-b2be-1fbaee0bff4c.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4a42d6f6-aa2b-4f6f-8f5b-627c2953ac07.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/29cbc32f-13ed-4995-aeac-1a08aaee9001.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/096a9d98-f105-463c-aca9-f3cdf4640f2e.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/500422/73165500422.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/500422/70945500422.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/500422/5004220320.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/500422/5004220319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/500422/5004220318.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:59:14.389Z.